129
Views
55
CrossRef citations to date
0
Altmetric
Original Research

Gum arabic-coated radioactive gold nanoparticles cause no short-term local or systemic toxicity in the clinically relevant canine model of prostate cancer

, , , , , , , , , , , & show all
Pages 5001-5011 | Published online: 28 Oct 2014

References

  • SiegelRNaishadhamDJemalACancer statistics, 2012CA Cancer J Clin2012621102922237781
  • CrookJThe role of brachytherapy in the definitive management of prostate cancerCancer Radiother201115323023721514199
  • MortonGCThe emerging role of high-dose-rate brachytherapy for prostate cancerClin Oncol (R Coll Radiol)200517421922715997914
  • DauffyLSBrabyLABernerBMDosimetry of the 198Au source used in interstitial brachytherapyMed Phys20053261579158816013717
  • PodderTKDickerAPHutapeaPDarvishKYuYA novel curvilinear approach for prostate seed implantationMed Phys20123941887189222482610
  • StoneNNStoneMMRosensteinBSUngerPStockRGInfluence of pretreatment and treatment factors on intermediate to long-term outcome after prostate brachytherapyJ Urol2011185249550021167528
  • StoneNNStockRGProstate brachytherapy: treatment strategiesJ Urol1999162242142610411050
  • ButlerEBScardinoPTTehBSThe Baylor College of Medicine experience with gold seed implantationSemin Surg Oncol19971364064189358587
  • PottersLKleinEAKattanMWMonotherapy for stage T1–T2 prostate cancer: radical prostatectomy, external beam radiotherapy, or permanent seed implantationRadiother Oncol2004711293315066293
  • KannanRRahingVCutlerCNanocompatible chemistry toward fabrication of target-specific gold nanoparticlesJ Am Chem Soc200612835113421134316939243
  • WaiteCLRothCMNanoscale drug delivery systems for enhanced drug penetration into solid tumors: current progress and opportunitiesCrit Rev Biomed Eng2012401214122428797
  • PapasaniMRWangGHillRAGold nanoparticles: the importance of physiological principles to devise strategies for targeted drug deliveryNanomedicine20128680481422306155
  • KattumuriVKattiKBhaskaranSGum arabic as a phytochemical construct for the stabilization of gold nanoparticles: in vivo pharmacokinetics and X-ray-contrast-imaging studiesSmall20073233334117262759
  • BooteEFentGKattumuriVGold nanoparticle contrast in a phantom and juvenile swine: models for molecular imaging of human organs using x-ray computed tomographyAcad Radiol201017441041720207313
  • KannanRZambreAChandaNFunctionalized radioactive gold nanoparticles in tumor therapyWiley Interdiscip Rev Nanomed Nanobiotechnol201241425121953803
  • ChandaNKanPWatkinsonLDRadioactive gold nanoparticles in cancer therapy: therapeutic efficacy studies of GA-198AuNP nanoconstruct in prostate tumor-bearing miceNanomedicine20106220120919914401
  • LiYWuPXuHZhangHZhongXAnti-aggregation of gold nanoparticle-based colorimetric sensor for glutathione with excellent selectivity and sensitivityAnalyst2011136119620020931106
  • WheloveOECozadMJLeeBDDevelopment and in vitro studies of a polyethylene terephthalate-gold nanoparticle scaffold for improved biocompatibilityJ Biomed Mater Res B Appl Biomater201199114214921714079
  • LystvetSMVoldenSYasudaMHalskauØJrGlommWREmergent membrane-affecting properties of BSA-gold nanoparticle constructsNanoscale2011341788179721359387
  • RivardMJCourseyBMDeWerdLAUpdate of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculationsMed Phys200431363367415070264
  • PorterATFormanJDProstate brachytherapy. An overviewCancer1993713 Suppl9539588428345
  • WiltTJMacDonaldRRutksIShamliyanTATaylorBCKaneRLSystematic review: comparative effectiveness and harms of treatments for clinically localized prostate cancerAnn Intern Med2008148643544818252677
  • ChowningSLSusilRCKriegerAFichtingerGWhitcombLLAtalarEA preliminary analysis and model of prostate injection distributionsProstate200666434435716302267
  • LeroyBENorthrupNProstate cancer in dogs: comparative and clinical aspectsVet J2009180214916218786842
  • LiangCHWangCCLinYCChenCHWongCHWuCYIron oxide/gold core/shell nanoparticles for ultrasensitive detection of carbohydrate-protein interactionsAnal Chem200981187750775619689135
  • ConversanoFSolopertoGGrecoAEchographic detectability of optoacoustic signals from low-concentration PEG-coated gold nanorodsInt J Nanomedicine201274373438922927756
  • HainfeldJFO’ConnorMJDilmanianFASlatkinDNAdamsDJSmilowitzHMMicro-CT enables microlocalisation and quantification of Her2-targeted gold nanoparticles within tumour regionsBr J Radiol201184100252653321081567
  • ReuveniTMotieiMRommanZPopovtzerAPopovtzerRTargeted gold nanoparticles enable molecular CT imaging of cancer: an in vivo studyInt J Nanomedicine201162859286422131831
  • GrabtchakSTonkopiEWhelanWMOptical detection of gold nanoparticles in a prostate-shaped porcine phantomJ Biomed Opt201318707700523864016
  • JohnstonHJHutchisonGChristensenFMPetersSHankinSStoneVA review of the in vivo and in vitro toxicity of silver and gold particulates: particle attributes and biological mechanisms responsible for the observed toxicityCrit Rev Toxicol201040432834620128631
  • LiYFChenCFate and toxicity of metallic and metal-containing nanoparticles for biomedical applicationsSmall20117212965298021932238
  • De JongWHHagensWIKrystekPBurgerMCSipsAJGeertsmaREParticle size-dependent organ distribution of gold nanoparticles after intravenous administrationBiomaterials200829121912191918242692
  • FentGMCasteelSWKimDYBiodistribution of maltose and gum arabic hybrid gold nanoparticles after intravenous injection in juvenile swineNanomedicine20095212813519480048
  • HainfeldJFSlatkinDNFocellaTMSmilowitzHMGold nanoparticles: a new X-ray contrast agentBr J Radiol20067993924825316498039
  • BryanJNKeelerMRHenryCJBryanMEHahnAWCaldwellCWA population study of neutering status as a risk factor for canine prostate cancerProstate200767111174118117516571
  • CornellKKBostwickDGCooleyDMClinical and pathologic aspects of spontaneous canine prostate carcinoma: a retrospective analysis of 76 casesProstate200045217318311027417